| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.08B | 2.07B | 2.06B | 1.77B | 1.61B |
| Gross Profit | 794.50M | 804.53M | 787.90M | 637.89M | 599.75M |
| EBITDA | 231.52M | 348.90M | 315.74M | 230.72M | 236.05M |
| Net Income | -14.47M | 106.85M | 128.68M | 18.70M | 40.21M |
Balance Sheet | |||||
| Total Assets | 2.10B | 2.08B | 1.89B | 1.81B | 1.68B |
| Cash, Cash Equivalents and Short-Term Investments | 385.44M | 369.12M | 549.61M | 632.59M | 640.17M |
| Total Debt | 481.49M | 425.87M | 377.28M | 371.82M | 293.26M |
| Total Liabilities | 790.54M | 721.55M | 627.95M | 629.62M | 504.56M |
| Stockholders Equity | 1.27B | 1.32B | 1.23B | 1.14B | 1.17B |
Cash Flow | |||||
| Free Cash Flow | 199.51M | 142.63M | 61.97M | 99.47M | 229.96M |
| Operating Cash Flow | 262.12M | 211.30M | 268.99M | 162.11M | 273.05M |
| Investing Cash Flow | -12.46M | 1.42M | -300.36M | -11.89M | 30.44M |
| Financing Cash Flow | -202.85M | -193.54M | -169.45M | -161.45M | -147.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | HK$3.30B | 8.02 | 12.93% | 3.74% | 22.72% | 41.32% | |
69 Neutral | HK$277.66M | 7.56 | 5.23% | 6.06% | -2.76% | 41.23% | |
68 Neutral | HK$1.69B | 9.28 | 5.22% | 10.34% | 2.23% | -11.23% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | HK$594.09M | -6.00 | -2.70% | 6.67% | 0.09% | -274.36% | |
46 Neutral | HK$239.42M | -19.22 | -6.67% | ― | -3.29% | -22.01% |